![]() |
인쇄하기
취소
|
A bill will be prepared to develop an indicator to assess the operational performance of ethical management by domestic pharmaceutical companies on their own and conduct inspections by visiting the pharmaceutical companies based on the indicator.
Moreover, a report is expected to be adopted to suggest countermeasures after observing the current state and problems of the pharmaceutical indust...